Prediction model for hyperprogressive disease in non‐small cell lung cancer treated with immune checkpoint inhibitors

BACKGROUND: Hyperprogressive disease (HPD) is a paradoxical acceleration of tumor growth after immune checkpoint inhibitor (ICI) treatment. This study aimed to identify the risk factors and to present a predictive model for HPD in patients treated with ICIs. METHODS: A total of 78 non‐small cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yong Jun, Kim, Taehee, Kim, Eun Young, Lee, Sang Hoon, Kwon, Do Sun, Chang, Yoon Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529559/
https://www.ncbi.nlm.nih.gov/pubmed/32779394
http://dx.doi.org/10.1111/1759-7714.13594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529559/
https://www.ncbi.nlm.nih.gov/pubmed/32779394
http://dx.doi.org/10.1111/1759-7714.13594

Ejemplares similares